Acorda Therapeutics Turns To Profit In Q1 - Quick Facts

(RTTNews) - Acorda Therapeutics Inc. (ACOR) reported net income of $0.7 million or $0.02 per share for the first quarter, compared to a net loss of $1.14 million or $0.03 per share last year.

Non-GAAP net income was $8.8 million or $0.21 per share, while it totaled $1.3 million or $0.03 per share last year.

On average, 11 analysts polled by Thomson Reuters expected earnings of $0.10 per share. Analysts' estimates typically exclude special items.

Total revenues increased to $80.52 million from $71.87 million in the prior year. Analysts expected revenues of $81.28 million.